Review



mouse anti α sma  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech mouse anti α sma
    Mouse Anti α Sma, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1287 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+%CE%B1+smooth+muscle+actin/smooth+muscle+actin+Polyclonal+antibody/pm41850661-136-5-9
    Average 96 stars, based on 1287 article reviews
    mouse anti α sma - by Bioz Stars, 2026-10
    96/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Fibrotic scar formation after cerebral ischemic stroke: Targeting the Sonic hedgehog signaling pathway for scar reduction
    Article Snippet: .. Membranes were blocked with 5% skim milk at room temperature for 2 hours and incubated overnight at 4°C with the following primary antibodies: rabbit anti-Shh (1:1000, Proteintech, Wuhan, China, Cat# 20697-1-AP, RRID: AB_10694828), rabbit anti-MFN2 (1:1000, Proteintech, Cat# 12186-1-AP, RRID: AB-2266320), rabbit anti-Smad3 (1:1000, CST, Boston, MA, USA, Cat# 9523S), rabbit anti-P-Smad3 (1:1000, CST, Cat# 9520S), mouse anti-fibronectin (Fn; 1:1000, Proteintech, Cat# 66042-1-Ig, RRID: AB-11182385), mouse anti-α-smooth muscle actin (α-SMA; 1:1000, Proteintech, Cat# 67735-1-Ig, RRID: AB-2918504) and rabbit anti-β-actin (1:5000, Proteintech, Cat# 81115-1-RR). .. After washing with Tris Buffered Saline with Tween 20, the membranes were incubated with secondary antibody (HRP-conjugated goat anti-rabbit IgG, 1:5000, Proteintech, Cat# SA00001-2, RRID: AB_2722564; HRP-conjugated Goat Anti-Rabbit IgG, 1:5000, Proteintech, Cat# SA00001-1, RRID: AB_2722565) for 1 hour at 37°C.

    Article Title: Fibrotic scar formation after cerebral ischemic stroke: targeting the Sonic hedgehog signaling pathway for scar reduction
    Article Snippet: .. Membranes were blocked with 5% skim milk at room temperature for 2 hours and incubated overnight at 4°C with the following primary antibodies: rabbit anti-Shh (1:1000, Proteintech, Wuhan, China, Cat# 20697-1-AP, RRID: AB_10694828), rabbit anti-MFN2 (1:1000, Proteintech, Cat# 12186-1-AP, RRID: AB-2266320), rabbit anti-Smad3 (1:1000, CST, Boston, MA, USA, Cat# 9523S), rabbit anti-P-Smad3 (1:1000, CST, Cat# 9520S), mouse anti-fibronectin (Fn; 1:1000, Proteintech, Cat# 66042-1-Ig, RRID: AB-11182385), mouse anti-α-smooth muscle actin (α-SMA; 1:1000, Proteintech, Cat# 67735-1-Ig, RRID: AB-2918504) and rabbit anti-β-actin (1:5000, Proteintech, Cat# 81115-1-RR). .. After washing with Tris Buffered Saline with Tween 20, the membranes were incubated with secondary antibody (HRP-conjugated goat anti-rabbit IgG, 1:5000, Proteintech, Cat# SA00001-2, RRID: AB_2722564; HRP-conjugated Goat Anti-Rabbit IgG, 1:5000, Proteintech, Cat# SA00001-1, RRID: AB_2722565) for 1 hour at 37°C.



    Similar Products

    95
    R&D Systems mouse anti α sma
    Mouse Anti α Sma, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+%CE%B1+smooth+muscle+actin/Human%2FMouse%2FRat+alpha-Smooth+Muscle+Actin+Antibody/pmc13115125-76-10-14
    Average 95 stars, based on 1 article reviews
    mouse anti α sma - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    93
    Novus Biologicals mouse monoclonal anti α smooth muscle actin α sma
    Histopathologic evaluation of ulcer healing. a Thickness of granulation tissue and representative images of Azan-Mallory staining in the rebamipide and control groups on POD 7 (Scale bar, 1000 µm). The rebamipide group exhibited a greater thickness of granulation tissue compared with the control group (718.0 ± 144.0 µm vs. 589.6 ± 84.9 µm), although this difference did not reach statistical significance (P = 0.12). b The number of microvessels and representative images <t>of</t> <t>α-SMA</t> sections in the rebamipide and control groups on POD 7 (Scale bar, 50 µm). Although the rebamipide group showed a greater number of microvessels (17.0 ± 3.4 vs. 13.8 ± 1.5), the difference was not statistically significant (P = 0.10). c Widths of absent muscularis mucosae and representative images of Azan Mallory staining in the rebamipide and control groups on PODs 7, 14 and 21 (Scale bar, 2500 µm for POD 7; 1000 µm for PODs 14 and 21). Mean widths in the rebamipide and control groups on PODs 7, 14, and 21 were 13.8 ± 2.8 ×10³/µm vs. 13.9 ± 2.2 ×10³/µm (P = 0.93), 4.0 ± 1.7 ×10³/µm vs. 5.3 ± 1.9 ×10³/µm (P = 0.33), and 2.3 ± 1.6 ×10³/µm vs. 3.5 ± 2.2 ×10³/µm (P = 0.37), respectively. Although widths tended to be shorter in the rebamipide group on PODs 14 and 21, no statistically significant differences were detected. Linear mixed‑effects analysis revealed no significant group-time interaction. α-SMA, α-smooth muscle actin; POD, postoperative day.
    Mouse Monoclonal Anti α Smooth Muscle Actin α Sma, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+%CE%B1+smooth+muscle+actin/alpha-Smooth+Muscle+Actin+Antibody+(1A4%2Fasm-1)+%5BPE%5D/pmc13093119-67-8-18
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti α smooth muscle actin α sma - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc anti α sma
    Histopathologic evaluation of ulcer healing. a Thickness of granulation tissue and representative images of Azan-Mallory staining in the rebamipide and control groups on POD 7 (Scale bar, 1000 µm). The rebamipide group exhibited a greater thickness of granulation tissue compared with the control group (718.0 ± 144.0 µm vs. 589.6 ± 84.9 µm), although this difference did not reach statistical significance (P = 0.12). b The number of microvessels and representative images <t>of</t> <t>α-SMA</t> sections in the rebamipide and control groups on POD 7 (Scale bar, 50 µm). Although the rebamipide group showed a greater number of microvessels (17.0 ± 3.4 vs. 13.8 ± 1.5), the difference was not statistically significant (P = 0.10). c Widths of absent muscularis mucosae and representative images of Azan Mallory staining in the rebamipide and control groups on PODs 7, 14 and 21 (Scale bar, 2500 µm for POD 7; 1000 µm for PODs 14 and 21). Mean widths in the rebamipide and control groups on PODs 7, 14, and 21 were 13.8 ± 2.8 ×10³/µm vs. 13.9 ± 2.2 ×10³/µm (P = 0.93), 4.0 ± 1.7 ×10³/µm vs. 5.3 ± 1.9 ×10³/µm (P = 0.33), and 2.3 ± 1.6 ×10³/µm vs. 3.5 ± 2.2 ×10³/µm (P = 0.37), respectively. Although widths tended to be shorter in the rebamipide group on PODs 14 and 21, no statistically significant differences were detected. Linear mixed‑effects analysis revealed no significant group-time interaction. α-SMA, α-smooth muscle actin; POD, postoperative day.
    Anti α Sma, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+%CE%B1+smooth+muscle+actin/alpha-Smooth+Muscle+Actin+Mouse+mAb/pm41915213-66-71-74
    Average 96 stars, based on 1 article reviews
    anti α sma - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Proteintech mouse anti α sma
    Histopathologic evaluation of ulcer healing. a Thickness of granulation tissue and representative images of Azan-Mallory staining in the rebamipide and control groups on POD 7 (Scale bar, 1000 µm). The rebamipide group exhibited a greater thickness of granulation tissue compared with the control group (718.0 ± 144.0 µm vs. 589.6 ± 84.9 µm), although this difference did not reach statistical significance (P = 0.12). b The number of microvessels and representative images <t>of</t> <t>α-SMA</t> sections in the rebamipide and control groups on POD 7 (Scale bar, 50 µm). Although the rebamipide group showed a greater number of microvessels (17.0 ± 3.4 vs. 13.8 ± 1.5), the difference was not statistically significant (P = 0.10). c Widths of absent muscularis mucosae and representative images of Azan Mallory staining in the rebamipide and control groups on PODs 7, 14 and 21 (Scale bar, 2500 µm for POD 7; 1000 µm for PODs 14 and 21). Mean widths in the rebamipide and control groups on PODs 7, 14, and 21 were 13.8 ± 2.8 ×10³/µm vs. 13.9 ± 2.2 ×10³/µm (P = 0.93), 4.0 ± 1.7 ×10³/µm vs. 5.3 ± 1.9 ×10³/µm (P = 0.33), and 2.3 ± 1.6 ×10³/µm vs. 3.5 ± 2.2 ×10³/µm (P = 0.37), respectively. Although widths tended to be shorter in the rebamipide group on PODs 14 and 21, no statistically significant differences were detected. Linear mixed‑effects analysis revealed no significant group-time interaction. α-SMA, α-smooth muscle actin; POD, postoperative day.
    Mouse Anti α Sma, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+%CE%B1+smooth+muscle+actin/smooth+muscle+actin+Polyclonal+antibody/pm41850661-136-5-9
    Average 96 stars, based on 1 article reviews
    mouse anti α sma - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Proteintech mouse anti smooth muscle α actin antibody
    Histopathologic evaluation of ulcer healing. a Thickness of granulation tissue and representative images of Azan-Mallory staining in the rebamipide and control groups on POD 7 (Scale bar, 1000 µm). The rebamipide group exhibited a greater thickness of granulation tissue compared with the control group (718.0 ± 144.0 µm vs. 589.6 ± 84.9 µm), although this difference did not reach statistical significance (P = 0.12). b The number of microvessels and representative images <t>of</t> <t>α-SMA</t> sections in the rebamipide and control groups on POD 7 (Scale bar, 50 µm). Although the rebamipide group showed a greater number of microvessels (17.0 ± 3.4 vs. 13.8 ± 1.5), the difference was not statistically significant (P = 0.10). c Widths of absent muscularis mucosae and representative images of Azan Mallory staining in the rebamipide and control groups on PODs 7, 14 and 21 (Scale bar, 2500 µm for POD 7; 1000 µm for PODs 14 and 21). Mean widths in the rebamipide and control groups on PODs 7, 14, and 21 were 13.8 ± 2.8 ×10³/µm vs. 13.9 ± 2.2 ×10³/µm (P = 0.93), 4.0 ± 1.7 ×10³/µm vs. 5.3 ± 1.9 ×10³/µm (P = 0.33), and 2.3 ± 1.6 ×10³/µm vs. 3.5 ± 2.2 ×10³/µm (P = 0.37), respectively. Although widths tended to be shorter in the rebamipide group on PODs 14 and 21, no statistically significant differences were detected. Linear mixed‑effects analysis revealed no significant group-time interaction. α-SMA, α-smooth muscle actin; POD, postoperative day.
    Mouse Anti Smooth Muscle α Actin Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+%CE%B1+smooth+muscle+actin/alpha+Actin+Antibody/pm41806029-105-10-26
    Average 96 stars, based on 1 article reviews
    mouse anti smooth muscle α actin antibody - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    94
    Bio-Rad anti human alpha smooth muscle actin α sma
    ( A ) Sorted CD45-cells (fibroblasts) were analyzed for expression of myofibroblast-related genes after co-culture with monocytes in collagen hydrogels. Values (mean ± SEM) indicate relative gene expression (−ΔCt) measured with qPCR. Reference genes used were GAPDH and RPS27A. Analyses were done by two-way ANOVA with Sidak’s multiple comparisons test (**p<0.01, ***p<0.001, ****p<0.0001). ( B ) Representative immunohistochemistry staining showing robust expression <t>of</t> <t>α-SMA</t> <t>(alpha-smooth</t> muscle actin) (left) and fibroblast activation protein (FAP) (right) in the hydrogels containing only fibroblasts (top) compared to those co-culture with monocytes (bottom). The small blue nuclei in the bottom panels are monocytes. (Myo)fibroblasts are clearly positive for both markers (black arrows), with a typically elongated shape.
    Anti Human Alpha Smooth Muscle Actin α Sma, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+%CE%B1+smooth+muscle+actin/Mouse+anti+Human+Actin+Alpha+(Smooth+Muscle)/bio_rxiv__64898__2026__02__12__705496-192-7-41
    Average 94 stars, based on 1 article reviews
    anti human alpha smooth muscle actin α sma - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Boster Bio mouse anti α smooth muscle actin α sma antibody
    ( A ) Sorted CD45-cells (fibroblasts) were analyzed for expression of myofibroblast-related genes after co-culture with monocytes in collagen hydrogels. Values (mean ± SEM) indicate relative gene expression (−ΔCt) measured with qPCR. Reference genes used were GAPDH and RPS27A. Analyses were done by two-way ANOVA with Sidak’s multiple comparisons test (**p<0.01, ***p<0.001, ****p<0.0001). ( B ) Representative immunohistochemistry staining showing robust expression <t>of</t> <t>α-SMA</t> <t>(alpha-smooth</t> muscle actin) (left) and fibroblast activation protein (FAP) (right) in the hydrogels containing only fibroblasts (top) compared to those co-culture with monocytes (bottom). The small blue nuclei in the bottom panels are monocytes. (Myo)fibroblasts are clearly positive for both markers (black arrows), with a typically elongated shape.
    Mouse Anti α Smooth Muscle Actin α Sma Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+%CE%B1+smooth+muscle+actin/Anti-Alpha-Smooth+Muscle+Actin+ACTA2+Antibody/pm41687828-64-5-11
    Average 94 stars, based on 1 article reviews
    mouse anti α smooth muscle actin α sma antibody - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Boster Bio mouse anti α 581 smooth muscle actin αsma monoclonal antibody
    ( A ) Sorted CD45-cells (fibroblasts) were analyzed for expression of myofibroblast-related genes after co-culture with monocytes in collagen hydrogels. Values (mean ± SEM) indicate relative gene expression (−ΔCt) measured with qPCR. Reference genes used were GAPDH and RPS27A. Analyses were done by two-way ANOVA with Sidak’s multiple comparisons test (**p<0.01, ***p<0.001, ****p<0.0001). ( B ) Representative immunohistochemistry staining showing robust expression <t>of</t> <t>α-SMA</t> <t>(alpha-smooth</t> muscle actin) (left) and fibroblast activation protein (FAP) (right) in the hydrogels containing only fibroblasts (top) compared to those co-culture with monocytes (bottom). The small blue nuclei in the bottom panels are monocytes. (Myo)fibroblasts are clearly positive for both markers (black arrows), with a typically elongated shape.
    Mouse Anti α 581 Smooth Muscle Actin αsma Monoclonal Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+%CE%B1+smooth+muscle+actin/Anti-Alpha-Smooth+Muscle+Actin+ACTA2+Antibody/pm41635085-271-17-26
    Average 94 stars, based on 1 article reviews
    mouse anti α 581 smooth muscle actin αsma monoclonal antibody - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    96
    Proteintech mouse anti α smooth muscle actin
    ( A ) Sorted CD45-cells (fibroblasts) were analyzed for expression of myofibroblast-related genes after co-culture with monocytes in collagen hydrogels. Values (mean ± SEM) indicate relative gene expression (−ΔCt) measured with qPCR. Reference genes used were GAPDH and RPS27A. Analyses were done by two-way ANOVA with Sidak’s multiple comparisons test (**p<0.01, ***p<0.001, ****p<0.0001). ( B ) Representative immunohistochemistry staining showing robust expression <t>of</t> <t>α-SMA</t> <t>(alpha-smooth</t> muscle actin) (left) and fibroblast activation protein (FAP) (right) in the hydrogels containing only fibroblasts (top) compared to those co-culture with monocytes (bottom). The small blue nuclei in the bottom panels are monocytes. (Myo)fibroblasts are clearly positive for both markers (black arrows), with a typically elongated shape.
    Mouse Anti α Smooth Muscle Actin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+%CE%B1+smooth+muscle+actin/smooth+muscle+actin-specific+Antibody/pmc12220689-84-65-71
    Average 96 stars, based on 1 article reviews
    mouse anti α smooth muscle actin - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    Image Search Results


    Histopathologic evaluation of ulcer healing. a Thickness of granulation tissue and representative images of Azan-Mallory staining in the rebamipide and control groups on POD 7 (Scale bar, 1000 µm). The rebamipide group exhibited a greater thickness of granulation tissue compared with the control group (718.0 ± 144.0 µm vs. 589.6 ± 84.9 µm), although this difference did not reach statistical significance (P = 0.12). b The number of microvessels and representative images of α-SMA sections in the rebamipide and control groups on POD 7 (Scale bar, 50 µm). Although the rebamipide group showed a greater number of microvessels (17.0 ± 3.4 vs. 13.8 ± 1.5), the difference was not statistically significant (P = 0.10). c Widths of absent muscularis mucosae and representative images of Azan Mallory staining in the rebamipide and control groups on PODs 7, 14 and 21 (Scale bar, 2500 µm for POD 7; 1000 µm for PODs 14 and 21). Mean widths in the rebamipide and control groups on PODs 7, 14, and 21 were 13.8 ± 2.8 ×10³/µm vs. 13.9 ± 2.2 ×10³/µm (P = 0.93), 4.0 ± 1.7 ×10³/µm vs. 5.3 ± 1.9 ×10³/µm (P = 0.33), and 2.3 ± 1.6 ×10³/µm vs. 3.5 ± 2.2 ×10³/µm (P = 0.37), respectively. Although widths tended to be shorter in the rebamipide group on PODs 14 and 21, no statistically significant differences were detected. Linear mixed‑effects analysis revealed no significant group-time interaction. α-SMA, α-smooth muscle actin; POD, postoperative day.

    Journal: Endoscopy International Open

    Article Title: Use of rebamipide solution as a submucosal injection material to prevent esophageal stricture after endoscopic submucosal dissection: Animal study

    doi: 10.1055/a-2820-3721

    Figure Lengend Snippet: Histopathologic evaluation of ulcer healing. a Thickness of granulation tissue and representative images of Azan-Mallory staining in the rebamipide and control groups on POD 7 (Scale bar, 1000 µm). The rebamipide group exhibited a greater thickness of granulation tissue compared with the control group (718.0 ± 144.0 µm vs. 589.6 ± 84.9 µm), although this difference did not reach statistical significance (P = 0.12). b The number of microvessels and representative images of α-SMA sections in the rebamipide and control groups on POD 7 (Scale bar, 50 µm). Although the rebamipide group showed a greater number of microvessels (17.0 ± 3.4 vs. 13.8 ± 1.5), the difference was not statistically significant (P = 0.10). c Widths of absent muscularis mucosae and representative images of Azan Mallory staining in the rebamipide and control groups on PODs 7, 14 and 21 (Scale bar, 2500 µm for POD 7; 1000 µm for PODs 14 and 21). Mean widths in the rebamipide and control groups on PODs 7, 14, and 21 were 13.8 ± 2.8 ×10³/µm vs. 13.9 ± 2.2 ×10³/µm (P = 0.93), 4.0 ± 1.7 ×10³/µm vs. 5.3 ± 1.9 ×10³/µm (P = 0.33), and 2.3 ± 1.6 ×10³/µm vs. 3.5 ± 2.2 ×10³/µm (P = 0.37), respectively. Although widths tended to be shorter in the rebamipide group on PODs 14 and 21, no statistically significant differences were detected. Linear mixed‑effects analysis revealed no significant group-time interaction. α-SMA, α-smooth muscle actin; POD, postoperative day.

    Article Snippet: Serial sections were cut for immunostaining using the mouse monoclonal anti-α-smooth muscle actin (α-SMA) antibody (1:400 dilution, 1A4/asm-1; Novus Biologicals, Littleton, Colorado, United States).

    Techniques: Staining, Control

    Histopathologic evaluation of fibrosis formation. a Proportion of α-SMA-positive cells and representative images of α-SMA sections in the rebamipide and control groups on PODs 7, 14, and 21 (Scale bar, 50 µm). Proportions of α‑SMA–positive cells in the rebamipide and control groups on PODs 7, 14, and 21 were 29.0 ± 9.1% vs. 35.1 ± 9.0% (P = 0.22), 24.3 ± 7.9% vs. 27.4 ± 7.5% (P = 0.52), and 19.2 ± 2.2% vs. 25.8 ± 7.4% (P = 0.18), respectively ( a ). Although none of these differences were statistically significant, the rebamipide group consistently showed lower proportions of α‑SMA–positive cells across all time points. Linear mixed‑effects analysis revealed no significant group–time interaction. b Thickness of fibrosis and representative images of Azan-Mallory staining in the rebamipide and control groups on PODs 7, 14, and 21 (Scale bar, 500 µm). Thickness of fibrosis in the rebamipide and control groups on PODs 7, 14, and 21 was 558.6 ± 169.7 µm vs. 450.8 ± 131.1 µm (P = 0.58), 807.0 ± 238.9 µm vs. 972.8 ± 395.1 µm (P = 0.40), and 782.8 ± 281.5 µm vs. 1087.0 ± 476.0 µm (P = 0.13), respectively. Fibrosis progressed on POD 7 but was attenuated on PODs 14 and 21 in the rebamipide group compared with the control group. Linear mixed‑effects analysis demonstrated a significant group–time interaction, with the between‑group difference becoming evident at POD 21 (P = 0.049). α-SMA, α-smooth muscle actin; POD, postoperative day

    Journal: Endoscopy International Open

    Article Title: Use of rebamipide solution as a submucosal injection material to prevent esophageal stricture after endoscopic submucosal dissection: Animal study

    doi: 10.1055/a-2820-3721

    Figure Lengend Snippet: Histopathologic evaluation of fibrosis formation. a Proportion of α-SMA-positive cells and representative images of α-SMA sections in the rebamipide and control groups on PODs 7, 14, and 21 (Scale bar, 50 µm). Proportions of α‑SMA–positive cells in the rebamipide and control groups on PODs 7, 14, and 21 were 29.0 ± 9.1% vs. 35.1 ± 9.0% (P = 0.22), 24.3 ± 7.9% vs. 27.4 ± 7.5% (P = 0.52), and 19.2 ± 2.2% vs. 25.8 ± 7.4% (P = 0.18), respectively ( a ). Although none of these differences were statistically significant, the rebamipide group consistently showed lower proportions of α‑SMA–positive cells across all time points. Linear mixed‑effects analysis revealed no significant group–time interaction. b Thickness of fibrosis and representative images of Azan-Mallory staining in the rebamipide and control groups on PODs 7, 14, and 21 (Scale bar, 500 µm). Thickness of fibrosis in the rebamipide and control groups on PODs 7, 14, and 21 was 558.6 ± 169.7 µm vs. 450.8 ± 131.1 µm (P = 0.58), 807.0 ± 238.9 µm vs. 972.8 ± 395.1 µm (P = 0.40), and 782.8 ± 281.5 µm vs. 1087.0 ± 476.0 µm (P = 0.13), respectively. Fibrosis progressed on POD 7 but was attenuated on PODs 14 and 21 in the rebamipide group compared with the control group. Linear mixed‑effects analysis demonstrated a significant group–time interaction, with the between‑group difference becoming evident at POD 21 (P = 0.049). α-SMA, α-smooth muscle actin; POD, postoperative day

    Article Snippet: Serial sections were cut for immunostaining using the mouse monoclonal anti-α-smooth muscle actin (α-SMA) antibody (1:400 dilution, 1A4/asm-1; Novus Biologicals, Littleton, Colorado, United States).

    Techniques: Control, Staining

    ( A ) Sorted CD45-cells (fibroblasts) were analyzed for expression of myofibroblast-related genes after co-culture with monocytes in collagen hydrogels. Values (mean ± SEM) indicate relative gene expression (−ΔCt) measured with qPCR. Reference genes used were GAPDH and RPS27A. Analyses were done by two-way ANOVA with Sidak’s multiple comparisons test (**p<0.01, ***p<0.001, ****p<0.0001). ( B ) Representative immunohistochemistry staining showing robust expression of α-SMA (alpha-smooth muscle actin) (left) and fibroblast activation protein (FAP) (right) in the hydrogels containing only fibroblasts (top) compared to those co-culture with monocytes (bottom). The small blue nuclei in the bottom panels are monocytes. (Myo)fibroblasts are clearly positive for both markers (black arrows), with a typically elongated shape.

    Journal: bioRxiv

    Article Title: Monocytes Strongly Induce (MYO)Fibroblast Contraction in a New 3D Skin Model to Understand the Inflammation-Fibrosis Axis in Systemic Sclerosis

    doi: 10.64898/2026.02.12.705496

    Figure Lengend Snippet: ( A ) Sorted CD45-cells (fibroblasts) were analyzed for expression of myofibroblast-related genes after co-culture with monocytes in collagen hydrogels. Values (mean ± SEM) indicate relative gene expression (−ΔCt) measured with qPCR. Reference genes used were GAPDH and RPS27A. Analyses were done by two-way ANOVA with Sidak’s multiple comparisons test (**p<0.01, ***p<0.001, ****p<0.0001). ( B ) Representative immunohistochemistry staining showing robust expression of α-SMA (alpha-smooth muscle actin) (left) and fibroblast activation protein (FAP) (right) in the hydrogels containing only fibroblasts (top) compared to those co-culture with monocytes (bottom). The small blue nuclei in the bottom panels are monocytes. (Myo)fibroblasts are clearly positive for both markers (black arrows), with a typically elongated shape.

    Article Snippet: Sections were then incubated with primary rabbit –anti-human alpha-smooth muscle actin (α-SMA) (1:200) (ab5694, Abcam, UK), – fibroblast activation protein (FAP) (1:100) (ab207178, Abcam), – Phospho-SMAD2 (1:100) (#3108L, CellSignaling, USA), – Phospho-Stat3 (1:50) (#9145, CellSignaling), or mouse anti-human – CD68 (#MCA1815, BioRad, USA) (1:200) antibodies, for 1 hour at room temperature.

    Techniques: Expressing, Co-Culture Assay, Gene Expression, Immunohistochemistry, Staining, Activation Assay